International journal of women's dermatology · 2026
Prevalence of preventive cancer screening in skin cancer survivors is greater compared to non-cancer individuals: a retrospective cross-sectional analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Keffer Sarah A Mullen, Ma Jihyun, Wysong Ashley
Аннотация
BACKGROUND: Although skin cancer survivors have an increased risk of future malignancies, many are unaware of this and may not undergo preventative screening.
OBJECTIVE: To evaluate skin cancer survivors' prevalence of breast, colorectal, cervical, and lung cancer screening.
METHODS: This is a retrospective cross-sectional analysis of The Behavioral Risk Factor Surveillance System database from 2017 to 2021 comparing skin cancer, other cancer, and non-cancer controls. Multivariate analysis compared screening rates, controlled for socioeconomic, chronic disease, and behavioral factors.
RESULTS: Compared to non-cancer controls, skin cancer survivors had higher odds of undergoing screening for breast (odds ratios [OR]: 1.35, 95% confidence interval [CI] 1.20-1.51), colorectal (OR 1.53, 95% CI 1.40-1.66), and cervical cancer (OR 1.32, 95% CI 1.12-1.56). Lung cancer screening rates were low and similar between skin cancer survivors and non-cancer individuals (OR 1.21, 95% CI 0.84-1.74). In a subset analysis of skin cancer survivors, those who had melanoma were less likely to be screened for breast and colorectal cancer.
LIMITATIONS: This study is based on anonymous, national survey data, relying on patient recall of their health information.
CONCLUSION: Skin cancer survivors undergo cancer screenings for breast, colorectal, and cervical cancer at higher rates compared to non-cancer controls. Melanoma survivors have lower rates of breast and colorectal screening compared to non-melanoma skin cancer survivors. Skin cancer survivors should be reminded of preventive cancer screening, particularly for lung cancer.
OBJECTIVE: To evaluate skin cancer survivors' prevalence of breast, colorectal, cervical, and lung cancer screening.
METHODS: This is a retrospective cross-sectional analysis of The Behavioral Risk Factor Surveillance System database from 2017 to 2021 comparing skin cancer, other cancer, and non-cancer controls. Multivariate analysis compared screening rates, controlled for socioeconomic, chronic disease, and behavioral factors.
RESULTS: Compared to non-cancer controls, skin cancer survivors had higher odds of undergoing screening for breast (odds ratios [OR]: 1.35, 95% confidence interval [CI] 1.20-1.51), colorectal (OR 1.53, 95% CI 1.40-1.66), and cervical cancer (OR 1.32, 95% CI 1.12-1.56). Lung cancer screening rates were low and similar between skin cancer survivors and non-cancer individuals (OR 1.21, 95% CI 0.84-1.74). In a subset analysis of skin cancer survivors, those who had melanoma were less likely to be screened for breast and colorectal cancer.
LIMITATIONS: This study is based on anonymous, national survey data, relying on patient recall of their health information.
CONCLUSION: Skin cancer survivors undergo cancer screenings for breast, colorectal, and cervical cancer at higher rates compared to non-cancer controls. Melanoma survivors have lower rates of breast and colorectal screening compared to non-melanoma skin cancer survivors. Skin cancer survivors should be reminded of preventive cancer screening, particularly for lung cancer.